Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Civettini

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Medicine|April 11, 2023
Single-center study on SARS-CoV-2 infection in patients affected by CML: Vaccination status and bosutinib therapy as possible protective factors for hospitalizationIvan Civettini, Laura Antolini, Filippo Brioschi, et al.
European Journal of Haematology|December 8, 2022
Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemiaElena Inzoli, Elena Crisà, Novella Pugliese, et al.
Oncology|March 11, 2025
Expression of Human Endogenous Retrovirus Env Gene Product Is a Hallmark of Sidedness in Operable Colorectal CancerMaria Dolci, Ivan Civettini, Pietro Francesco Bagnoli, et al.
British Journal of Haematology|December 9, 2023
Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-makingIvan Civettini, Arianna Zappaterra, Bianca Maria Granelli, et al.
Biomedicines|January 8, 2025
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven MalignanciesFederica Malighetti, Matteo Villa, Mario Mauri, et al.
Med (New York, N.Y.)|December 19, 2024
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotypeIvan Civettini, Arianna Zappaterra, Paola Corti, et al.
Blood Transfusion = Trasfusione Del Sangue|February 5, 2024
Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patientsArianna Zappaterra, Ivan Civettini, Anna Maria Cafro, et al.
NEJM Evidence|May 26, 2026
Prognostic Score for Myelodysplastic Syndromes Based on Molecular EvolutionIvan Civettini, Federica Malighetti, Matteo Villa, et al.
Blood|January 9, 2024
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosisIlaria Crespiatico, Mattia Zaghi, Cristina Mastini, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Medicine|April 11, 2023
Single-center study on SARS-CoV-2 infection in patients affected by CML: Vaccination status and bosutinib therapy as possible protective factors for hospitalizationIvan Civettini, Laura Antolini, Filippo Brioschi, et al.
European Journal of Haematology|December 8, 2022
Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemiaElena Inzoli, Elena Crisà, Novella Pugliese, et al.
Oncology|March 11, 2025
Expression of Human Endogenous Retrovirus Env Gene Product Is a Hallmark of Sidedness in Operable Colorectal CancerMaria Dolci, Ivan Civettini, Pietro Francesco Bagnoli, et al.
British Journal of Haematology|December 9, 2023
Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-makingIvan Civettini, Arianna Zappaterra, Bianca Maria Granelli, et al.
Biomedicines|January 8, 2025
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven MalignanciesFederica Malighetti, Matteo Villa, Mario Mauri, et al.
Med (New York, N.Y.)|December 19, 2024
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotypeIvan Civettini, Arianna Zappaterra, Paola Corti, et al.
Blood Transfusion = Trasfusione Del Sangue|February 5, 2024
Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patientsArianna Zappaterra, Ivan Civettini, Anna Maria Cafro, et al.
NEJM Evidence|May 26, 2026
Prognostic Score for Myelodysplastic Syndromes Based on Molecular EvolutionIvan Civettini, Federica Malighetti, Matteo Villa, et al.
Blood|January 9, 2024
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosisIlaria Crespiatico, Mattia Zaghi, Cristina Mastini, et al.
Pageof 1